Prosecution Insights
Last updated: August 14, 2026

Rambam Med-Tech Ltd.

5 pending office actions • 4 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Portfolio Summary

5
Total Pending OAs
2
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (60%)
2
Medium (40%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (20%)
§103 only2 (40%)
Multi-statute (no §101)2 (40%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

3
Life Sciences
60% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
40% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

50 h
Manual time on pending OAs
10 h
Time saved (low, 20%)
18 h
Time saved (mid, 35%)
0.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SALMON, KATHERINE D 1 42.6% +38.0%
MYERS, CARLA J 1 49.0% +46.6%
AUDET, MAURY A 1 50.0% +23.8%
PAZ ESTEVEZ, GUILLERMO G 1 15.4% +13.9%
FERNANDEZ, KATHERINE L 1 57.9% +38.1%

Hard Cases (4)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18538027 METHOD FOR DETERMINING SUITABILITY TO ANTI-TNF ALPHA THERAPY SALMON, KATHERINE D
18033582 METHODS OF ASSESSING THE THERAPEUTIC ACTIVITY OF AGENTS FOR THE TREATMENT OF IMMUNE DISORDERS MYERS, CARLA J
18004821 TYROSINE, TRYPTOPHAN AND PHENYLALANINE AS mTOR AGONISTS MEDIATING PROTEASOME DYNAMICS, COMPOSITIONS, METHODS AND USES THEREOF IN THERAPY, AND PROGNOSTIC METHODS FOR DRUG-RESISTANCE AUDET, MAURY A
17431230 COMPOSITION, DRUG DELIVERY DEVICE AND METHOD FOR LOCAL DELIVERY OF AN ACTIVE AGENT PAZ ESTEVEZ, GUILLERMO G

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
16835608 INDUCING WEIGHT LOSS BY APPLICATION OF ENERGY FERNANDEZ, KATHERINE L 88d overdue
18538027 METHOD FOR DETERMINING SUITABILITY TO ANTI-TNF ALPHA THERAPY SALMON, KATHERINE D
18033582 METHODS OF ASSESSING THE THERAPEUTIC ACTIVITY OF AGENTS FOR THE TREATMENT OF IMMUNE DISORDERS MYERS, CARLA J
18004821 TYROSINE, TRYPTOPHAN AND PHENYLALANINE AS mTOR AGONISTS MEDIATING PROTEASOME DYNAMICS, COMPOSITIONS, METHODS AND USES THEREOF IN THERAPY, AND PROGNOSTIC METHODS FOR DRUG-RESISTANCE AUDET, MAURY A
17431230 COMPOSITION, DRUG DELIVERY DEVICE AND METHOD FOR LOCAL DELIVERY OF AN ACTIVE AGENT PAZ ESTEVEZ, GUILLERMO G

Top Art Units

Art UnitApps
1682 2
1654 1
3783 1
3798 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18538027 METHOD FOR DETERMINING SUITABILITY TO ANTI-TNF ALPHA THERAPY SALMON, KATHERINE D 1682 §102§103§112 Non-Final OA Pending Dec 13, 2023
18033582 METHODS OF ASSESSING THE THERAPEUTIC ACTIVITY OF AGENTS FOR THE TREATMENT OF IMMUNE DISORDERS MYERS, CARLA J 1682 §101§112 Non-Final OA Pending Apr 25, 2023
18004821 TYROSINE, TRYPTOPHAN AND PHENYLALANINE AS mTOR AGONISTS MEDIATING PROTEASOME DYNAMICS, COMPOSITIONS, METHODS AND USES THEREOF IN THERAPY, AND PROGNOSTIC METHODS FOR DRUG-RESISTANCE AUDET, MAURY A 1654 §102§103§112 Final Rejection Pending Jan 09, 2023
17431230 COMPOSITION, DRUG DELIVERY DEVICE AND METHOD FOR LOCAL DELIVERY OF AN ACTIVE AGENT PAZ ESTEVEZ, GUILLERMO G 3783 §103 Final Rejection Pending Aug 16, 2021
16835608 INDUCING WEIGHT LOSS BY APPLICATION OF ENERGY FERNANDEZ, KATHERINE L 3798 §103 Final Rejection 88d overdue Pending Mar 31, 2020

Managing Rambam Med-Tech Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month